Hybrid Nanoparticles Modified by Hyaluronic Acid Loading an HSP90 Inhibitor as a Novel Delivery System for Subcutaneous and Orthotopic Colon Cancer Therapy

Hybrid Nanoparticles Modified by Hyaluronic Acid Loading an HSP90 Inhibitor as a Novel Delivery System for Subcutaneous and Orthotopic Colon Cancer Therapy

Chenwei Pan,1,* Tiaotiao Zhang,2,3,* Shaoxun Li,1,3,* Zhihua Xu,2,3 Binhui Pan,2,3 Sheng Xu,2,3 Shuanghong Jin,1,3 Guangrong Lu,2 Shouxing Yang,2 Zhanxiong Xue,2 Ping Chen,4 Xian Shen,5 Fangyan Wang,6 Changlong Xu2,7 1Department of Infectious Disease, Second Affiliated Hospital and Yuying Children&a...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Pan C, Zhang T, Li S, Xu Z, Pan B, Xu S, Jin S, Lu G, Yang S, Xue Z, Chen P, Shen X, Wang F, Xu C
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2021
Materias:
cationic hybrid nanoparticles
hyaluronic acid (ha)
hsp90 inhibitor
colon cancer
targeted delivery system
Medicine (General)
R5-920
Acceso en línea:https://doaj.org/article/59eef45e92c945498fd61626b92a6e41
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/59eef45e92c945498fd61626b92a6e41

Ejemplares similares